miR-1247-3p and its role in chemoresistance in colorectal cancer
Author Information
Author(s): Wang Dequan, Wang Jielian, Yao Fei, Xie Zhufu, Wu Jianze, Chen Huiguang, Wu Qingming
Primary Institution: Wuhan University of Science and Technology
Hypothesis
The study investigates the role of miR-1247-3p in regulating chemoresistance in colorectal cancer by targeting CCND1.
Conclusion
The study found that miR-1247-3p reduces chemotherapy resistance in colorectal cancer by inhibiting CCND1 expression.
Supporting Evidence
- miR-1247-3p expression was significantly lower in drug-resistant colorectal cancer cells compared to sensitive cells.
- Overexpression of miR-1247-3p led to increased apoptosis and reduced drug resistance in colorectal cancer cells.
- CCND1 was identified as a target gene of miR-1247-3p, with its expression inversely correlated with miR-1247-3p levels.
Takeaway
This study shows that a tiny molecule called miR-1247-3p can help cancer cells respond better to treatment by stopping another molecule, CCND1, from working too much.
Methodology
The study used cell culture, RNA sequencing, RT-qPCR, MTT assays, and flow cytometry to analyze the effects of miR-1247-3p on colorectal cancer cells.
Limitations
The study primarily relied on in vitro experiments and has not yet been validated in animal models or clinical samples.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website